With the advancement of centralised procurement and hospital entry barriers for medicines, the out-of-hospital market is emerging as a key strategic focus for pharmaceutical companies evaluating new opportunities. Amid this industry transformation, both drug developers and retail pharmacies must proactively adapt to shifting dynamics and capitalise on evolving trends.